CLINICAL AND NEUROLOGICAL FEATURES OF HYPOTHERMIA IN CHILDREN
Hypothermia in children, defined as a fall in core body temperature below 35 °C, is usually associated with cold exposure, but in everyday pediatric practice it increasingly develops as a complication of drug treatment. In young children with acute respiratory viral infections, antipyretics (metamizole, paracetamol, ibuprofen), sedating antihistamines (diphenhydramine) and imidazoline nasal decongestants (naphazoline, xylometazoline, oxymetazoline) can lower body temperature and depress the central nervous system. Age-related features of the central nervous system, including incomplete maturation of thermoregulation and developmental differences in drug disposition and drug sensitivity, make children of early age, especially those aged 1–3 years, particularly vulnerable. This paper reviews literature published from 2000 to 2025 on the mechanisms of thermoregulation in children, the role of central nervous system immaturity, and the clinical-neurological manifestations, differential diagnosis and outcome of drug-associated hypothermia. The review shows that the neurological picture is dominated by depressed consciousness, ranging from drowsiness and lethargy to stupor and coma; that drug-associated hypothermia usually develops within hours after drug administration and resolves within 24 hours; and that it may mimic sepsis, central nervous system infection or poisoning.
Authors
- Worldly Knowledge Publishing Centre
- Azimova N.M.
- Tashbaeva Sh.S.
Publication Details
- Journal
- HSR (London)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.5281/zenodo.24322605
- Primary Topic
- Thermal Regulation in Medicine
- Type
- article
- Field-Weighted Citation Impact
- 0.00